SPRB

Spruce Biosciences, Inc. Common Stock

35 hedge funds and large institutions have $24.7M invested in Spruce Biosciences, Inc. Common Stock in 2022 Q3 according to their latest regulatory filings, with 3 funds opening new positions, 6 increasing their positions, 10 reducing their positions, and 4 closing their positions.

New
Increased
Maintained
Reduced
Closed
Holders
35
Holders Change
Holders Change %
% of All Funds
Holding in Top 10
1
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
New
Increased
Reduced
Closed
Calls
Puts
Net Calls
Net Calls Change

Top Buyers

1 +$3.34M
2 +$39.4K
3 +$21.9K
4
Vanguard Group
Vanguard Group
Pennsylvania
+$16.6K
5
Citadel Advisors
Citadel Advisors
Florida
+$9.5K

Top Sellers

1 -$84K
2 -$74.6K
3 -$69.9K
4
E
Ergoteles
New York
-$35.2K
5
VF
Virtu Financial
New York
-$27K
Name Holding Trade Value Shares
Change
Change in
Stake
26
$13.8K
27
$10K
28
$10K
29
$2K
30
$2K
31
$1K
32
$1K
33
$1K
34
35
36
37